MUSTANG BIO, INC. Increase (Decrease) in Prepaid Expenses, Other
MUSTANG BIO, INC. (MBIO) reported Increase (Decrease) in Prepaid Expenses, Other of -$413.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2019-08-09
- MUSTANG BIO, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2019-06-30 was -$148.00K, a 214.73% decline year-over-year.
- MUSTANG BIO, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2019-03-31 was -$265.00K, a 132.00% decline year-over-year.
- MUSTANG BIO, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2018-06-30 was $129.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2018-03-31 was $828.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expenses, other for fiscal 2018 was $757.00K, a 172.30% increase from fiscal 2017.
- MUSTANG BIO, INC. increase (decrease) in prepaid expenses, other for fiscal 2017 was $278.00K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|
| 2019-06-30 | -$148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$413.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$265.00K 10-Q · filed 2019-05-10 | ||
| 2018-12-31 | $757.00K 10-K · filed 2019-03-18 | ||
| 2018-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $957.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $828.00K 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | $278.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |